NeurologyWire

FDA Approves Migraine Drug For Pediatric Patients

From NeurologyWire

FDA has approved Treximet (sumatriptan and naproxen sodium) for use in pediatric patients 12 years of age and older for the acute treatment of migraine with or without aura.It is the first approved combination prescription medicine, and the first to contain sumatriptan, for the treatment of acute migraine attacks in pediatric patients. The two medi...

Login to read story

Thursday, May 14, 2015

Show last days of articles

Teva Presents Phase IIb Data on TEV-48125 for Chronic Migrai...

From NeurologyWire

Teva will present further data from its chronic migraine Phase IIb study evaluating two doses of TEV-48125, an anti-calcitonin gene-related peptide (C...Full story

An Animal Study Finds New Link Between Alzheimers and Diabet...

From NeurologyWire

Researchers have uncovered a unique connection between diabetes and Alzheimers disease, providing further evidence that a disease that robs people of ...Full story

Mediterranean Diet Supplemented with Olive Oil or Nuts Assoc...

From NeurologyWire

Supplementing the plant-based Mediterranean diet with antioxidant-rich extra virgin olive oil or mixed nuts was associated with improved cognitive fun...Full story

Most Concussions in High School and College Occur During Pra...

From NeurologyWire

A slight majority of concussions happened during youth football games but most concussions at the high school and college levels occurred during pract...Full story

Marijuana Pill May Not Be Effective in Treating Behavioral S...

From NeurologyWire

A new study suggests that medical marijuana pills may not help treat behavioral symptoms of dementia, such as aggression, pacing and wandering. The re...Full story

MS Patients Produce Different Types of Cytokines Than Contro...

From NeurologyWire

Evidence has long suggested multiple sclerosis (MS) is an autoimmune disease, but researchers have been puzzled because they found the same T cells th...Full story

Monday, May 11, 2015

FDA Approves Spinal Cord Stimulation System For Pain

From NeurologyWire

FDA has approved the Senza spinal cord stimulation (SCS) system (Senza System) as an aid in the management of chronic intractable pain of the trunk an...Full story

Friday, May 08, 2015

Bright Idea: Using Light To Activate Opioid Receptors and Re...

From NeurologyWire

In a test tube, the scientists melded the light-sensing protein rhodopsin to key parts of opioid receptors to activate receptor pathways using light. ...Full story

New Research Finds 'Fuzzy Thinking' in Depression & Bipolar ...

From NeurologyWire

People with depression or bipolar disorder often feel their thinking ability has gotten "fuzzy", or less sharp than before their symptoms began. Now, ...Full story

FDA Lifts Clinical Hold on Subcutaneous Levodopa/Carbidopa

From NeurologyWire

NeuroDerm announced FDA has lifted the clinical hold on US clinical studies of ND0612H and ND0612L, the company's primary product candidates, that are...Full story

Comprehensive Stroke Centers Best for Hemorrhagic Stroke Sur...

From NeurologyWire

People with hemorrhagic strokes (brain bleeds) are more likely to survive if they are treated at a comprehensive stroke center, according to research ...Full story

Wednesday, May 06, 2015

Medtronic Announces FDA Clearance and US Launch of Semicompl...

From NeurologyWire

Medtronic said FDA has issued clearance of the Euphora Semicompliant Balloon Dilatation Catheter, a pre-dilatation therapy used during a stent implant...Full story

The Myth of Restenosis After Carotid Angioplasty and Stentin...

From NeurologyWire

Winner of the DePuy Synthes Cerebrovascular Section Resident/Fellow Award,Karam Moon, MD, presented his research, The Myth of Restenosis after Carotid...Full story

Delays from Pain Diagnosis to Pain Surgery Result in Higher ...

From NeurologyWire

Winner of the William H. Sweet Young Investigators Award, Frank William Petraglia III, presented his research on the relationship between the efficacy...Full story

Tuesday, May 05, 2015

Phase I Clinical Trial of Oncolytic Delta-24-RGD: Implicatio...

From NeurologyWire

Winner of the Journal on Neuro-Oncology Award, Frederick F. Lang Jr., MD,FAANS, recently presented his research into Delta-24-RGD at the 2015 American...Full story